Zacks Initiates Coverage of VHI With Underperform Recommendation

Impact · against what's priced in

Zacks' initiation of coverage with an 'Underperform' rating for VHI highlights fundamental headwinds in the titanium dioxide market and increasing financial risk. The negative outlook is driven by heavy revenue concentration in a struggling chemicals segment and deteriorating balance sheet flexibility.

VHI−0.60

No priced-in read yet

In context

The initiation of coverage with an 'Underperform' rating is driven by significant pricing pressure and weak demand in the titanium dioxide market, which accounts for nearly 90% of revenues, alongside rising debt levels and interest expenses.

Read from the article alone

• VHI
• chemicals
• diversified holdings
• microcap
• pricing pressure
• real estate development
• titanium dioxide
• underperform

Search tags